About ClearView Diagnostics
Koios Medical is a healthcare technology company specializing in AI-powered clinical decision support software for cancer diagnosis. The company's flagship Smart Ultrasound platform combines artificial intelligence and machine learning to assist radiologists and physicians in accurately diagnosing breast and thyroid cancers through ultrasound imaging. Their Koios DS (Decision Support) software is built on an ensemble of algorithms trained on a proprietary dataset of over 2 million ultrasound images, analyzing 17,900 features per image to classify lesions and render cancer risk assessments aligned with BI-RADS and ATA guidelines. The software has received FDA 510(k) clearance and CE marking, making it a billable procedure. With over 101 installations across 28 countries, Koios Medical serves radiologists, breast imaging specialists, and healthcare systems worldwide. The technology integrates seamlessly into existing PACS workstations, providing real-time analysis in seconds. Clinical studies have demonstrated that the software improves diagnostic accuracy, detects up to 6 more cancers per 100 cases interpreted, and has the potential to reduce benign biopsies by 31-40%. The company's mission focuses on improving cancer survival rates while enhancing workflow efficiency for healthcare providers. Koios Medical has attracted investment from major partners including Mitsui & Co., and continues to expand its global footprint with 1-2 new site activations per week.
Clinical Focus
Medical conditions and clinical areas addressed by ClearView Diagnostics.
Who It Serves
Milestones & Awards
Recent Milestones
101 installations across 28 countries as of July 2022, 1-2 new site activations per week, investment from Mitsui & Co. in February 2023, perfect performance in invasive lobular carcinoma study published August 2023
Key Partnerships
Company Details
- Headquarters
- New York City, NY, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.